Literature DB >> 20729331

Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.

Seyma Charni1, Geoffroy de Bettignies, Moeez G Rathore, Juan I Aguiló, Peter J van den Elsen, Delphine Haouzi, Robert A Hipskind, José Antonio Enriquez, Margarita Sanchez-Beato, Julián Pardo, Alberto Anel, Martin Villalba.   

Abstract

Most cancer cells use anaerobic-like glycolysis to generate energy instead of oxidative phosphorylation. They also avoid recognition by CTLs, which occurs primarily through decreasing the level of MHC class I (MHC-I) at the cell surface. We find that the two phenomena are linked; culture conditions that force respiration in leukemia cells upregulate MHC-I transcription and protein levels at the cell surface, whereas these decrease in cells forced to perform fermentation as well as in leukemia cells lacking a functional mitochondrial respiratory chain. Forced respiration leads to increased expression of the MAPK ERK5, which activates MHC-I gene promoters, and ERK5 accumulation in mitochondria. Respiration-induced MHC-I upregulation is reversed upon short hairpin RNA-mediated ERK5 downregulation and by inactive mutants of ERK5. Moreover, short hairpin RNA for ERK5 leukemia cells do not tolerate forced respiration. Thus, the expression of ERK5 and MHC-I is linked to cell metabolism and notably diminished by the metabolic adaptations found in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729331     DOI: 10.4049/jimmunol.1001250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.

Authors:  Elena Catalán; Seyma Charni; Paula Jaime; Juan Ignacio Aguiló; José Antonio Enríquez; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 2.  The Warburg effect: molecular aspects and therapeutic possibilities.

Authors:  Hanh Ngo; Stephanie M Tortorella; Katherine Ververis; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

3.  IFNα signaling through PKC-θ is essential for antitumor NK cell function.

Authors:  Natalia R Comet; Juan Ignacio Aguiló; Moeez G Rathoré; Elena Catalán; Johan Garaude; Gilles Uzé; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

Review 4.  Vaccines for established cancer: overcoming the challenges posed by immune evasion.

Authors:  Sjoerd H van der Burg; Ramon Arens; Ferry Ossendorp; Thorbald van Hall; Cornelis J M Melief
Journal:  Nat Rev Cancer       Date:  2016-03-11       Impact factor: 60.716

5.  The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.

Authors:  Xuening Wang; Stella Pesakhov; Jonathan S Harrison; Michael Kafka; Michael Danilenko; George P Studzinski
Journal:  Exp Cell Res       Date:  2014-10-16       Impact factor: 3.905

6.  Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Authors:  Hong Jiang; Ping Wang; Xiaohua Li; Qilong Wang; Zhong-Bin Deng; Xiaoying Zhuang; Jingyao Mu; Lifeng Zhang; Baomei Wang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

Review 7.  Chemical metabolic inhibitors for the treatment of blood-borne cancers.

Authors:  Martin Villalba; Nuria Lopez-Royuela; Ewelina Krzywinska; Moeez G Rathore; Robert A Hipskind; Houda Haouas; Nerea Allende-Vega
Journal:  Anticancer Agents Med Chem       Date:  2014-02       Impact factor: 2.505

Review 8.  The invisible arm of immunity in common cancer chemoprevention agents.

Authors:  Edmond Marzbani; Carol Inatsuka; Hailing Lu; Mary L Disis
Journal:  Cancer Prev Res (Phila)       Date:  2013-08

Review 9.  Impaired mitochondrial metabolism and mammary carcinogenesis.

Authors:  Nagendra Yadava; Sallie S Schneider; D Joseph Jerry; Chul Kim
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-12-27       Impact factor: 2.673

10.  The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.

Authors:  Sandra Cristea; Garry L Coles; Daniel Hornburg; Maya Gershkovitz; Julia Arand; Siqi Cao; Triparna Sen; Stuart C Williamson; Jun W Kim; Alexandros P Drainas; Andrew He; Laurent Le Cam; Lauren Averett Byers; Michael P Snyder; Kévin Contrepois; Julien Sage
Journal:  Cancer Res       Date:  2020-01-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.